Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors

Anna Vulpetti, Elena Casale, Fulvia Roletto, Raffaella Amici, Manuela Villa, Paolo Pevarello

Research output: Contribution to journalArticle

Abstract

N-(5-Bromo-1,3-thiazol-2-yl)butanamide (compound 1) was found active (IC50 = 808 nM) in a high throughput screening (HTS) for CDK2 inhibitors. By exploiting crystal structures of several complexes between CDK2 and inhibitors and applying structure-based drug design (SBDD), we rapidly discovered a very potent and selective CDK2 inhibitor 4-[(5-isopropyl-1,3- thiazol-2-yl)amino] benzenesulfonamide (compound 4, IC50 = 20 nM). The syntheses, structure-based analog design, kinases inhibition data and X-ray crystallographic structures of CDK2/inhibitor complexes are reported.

Original languageEnglish
Pages (from-to)341-348
Number of pages8
JournalJournal of Molecular Graphics and Modelling
Volume24
Issue number5
DOIs
Publication statusPublished - Mar 2006

Fingerprint

inhibitors
drugs
Pharmaceutical Preparations
Screening
Phosphotransferases
Crystal structure
Throughput
X rays
screening
analogs
crystal structure
2-aminothiazole
synthesis
x rays
benzenesulfonamide

Keywords

  • CDK2
  • Crystal structures
  • Cyclin-dependent kinase
  • Ligand docking
  • Ligand-protein interactions
  • Structure-based drug design

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Spectroscopy
  • Atomic and Molecular Physics, and Optics

Cite this

Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors. / Vulpetti, Anna; Casale, Elena; Roletto, Fulvia; Amici, Raffaella; Villa, Manuela; Pevarello, Paolo.

In: Journal of Molecular Graphics and Modelling, Vol. 24, No. 5, 03.2006, p. 341-348.

Research output: Contribution to journalArticle

Vulpetti, Anna ; Casale, Elena ; Roletto, Fulvia ; Amici, Raffaella ; Villa, Manuela ; Pevarello, Paolo. / Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors. In: Journal of Molecular Graphics and Modelling. 2006 ; Vol. 24, No. 5. pp. 341-348.
@article{d51c8642d7b245769992e8a1092dcfce,
title = "Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors",
abstract = "N-(5-Bromo-1,3-thiazol-2-yl)butanamide (compound 1) was found active (IC50 = 808 nM) in a high throughput screening (HTS) for CDK2 inhibitors. By exploiting crystal structures of several complexes between CDK2 and inhibitors and applying structure-based drug design (SBDD), we rapidly discovered a very potent and selective CDK2 inhibitor 4-[(5-isopropyl-1,3- thiazol-2-yl)amino] benzenesulfonamide (compound 4, IC50 = 20 nM). The syntheses, structure-based analog design, kinases inhibition data and X-ray crystallographic structures of CDK2/inhibitor complexes are reported.",
keywords = "CDK2, Crystal structures, Cyclin-dependent kinase, Ligand docking, Ligand-protein interactions, Structure-based drug design",
author = "Anna Vulpetti and Elena Casale and Fulvia Roletto and Raffaella Amici and Manuela Villa and Paolo Pevarello",
year = "2006",
month = "3",
doi = "10.1016/j.jmgm.2005.09.012",
language = "English",
volume = "24",
pages = "341--348",
journal = "Journal of Molecular Graphics and Modelling",
issn = "1093-3263",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors

AU - Vulpetti, Anna

AU - Casale, Elena

AU - Roletto, Fulvia

AU - Amici, Raffaella

AU - Villa, Manuela

AU - Pevarello, Paolo

PY - 2006/3

Y1 - 2006/3

N2 - N-(5-Bromo-1,3-thiazol-2-yl)butanamide (compound 1) was found active (IC50 = 808 nM) in a high throughput screening (HTS) for CDK2 inhibitors. By exploiting crystal structures of several complexes between CDK2 and inhibitors and applying structure-based drug design (SBDD), we rapidly discovered a very potent and selective CDK2 inhibitor 4-[(5-isopropyl-1,3- thiazol-2-yl)amino] benzenesulfonamide (compound 4, IC50 = 20 nM). The syntheses, structure-based analog design, kinases inhibition data and X-ray crystallographic structures of CDK2/inhibitor complexes are reported.

AB - N-(5-Bromo-1,3-thiazol-2-yl)butanamide (compound 1) was found active (IC50 = 808 nM) in a high throughput screening (HTS) for CDK2 inhibitors. By exploiting crystal structures of several complexes between CDK2 and inhibitors and applying structure-based drug design (SBDD), we rapidly discovered a very potent and selective CDK2 inhibitor 4-[(5-isopropyl-1,3- thiazol-2-yl)amino] benzenesulfonamide (compound 4, IC50 = 20 nM). The syntheses, structure-based analog design, kinases inhibition data and X-ray crystallographic structures of CDK2/inhibitor complexes are reported.

KW - CDK2

KW - Crystal structures

KW - Cyclin-dependent kinase

KW - Ligand docking

KW - Ligand-protein interactions

KW - Structure-based drug design

UR - http://www.scopus.com/inward/record.url?scp=33644615052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644615052&partnerID=8YFLogxK

U2 - 10.1016/j.jmgm.2005.09.012

DO - 10.1016/j.jmgm.2005.09.012

M3 - Article

C2 - 16260160

AN - SCOPUS:33644615052

VL - 24

SP - 341

EP - 348

JO - Journal of Molecular Graphics and Modelling

JF - Journal of Molecular Graphics and Modelling

SN - 1093-3263

IS - 5

ER -